Your browser doesn't support javascript.
External Validation of the COVID-NoLab and COVID-SimpleLab Prognostic Tools.
Ebell, Mark H; Lennon, Robert P; Tarn, Derjung M; Barrett, Bruce; Krist, Alex H; Dong, Huamei; Cai, Xinyan; Mainous, Arch G; Zgierska, Aleksandra E; Tuan, Wen-Jan; Goyal, Munish.
  • Ebell MH; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia ebell@uga.edu.
  • Lennon RP; Department of Family and Community Medicine, Penn State College of Medicine, Hershey, Pennsylvania.
  • Tarn DM; Department of Family Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California.
  • Barrett B; Department of Family Medicine and Community Health, University of Wisconsin, Madison, Wisconsin.
  • Krist AH; Department of Family Medicine, Virginia Commonwealth University, Richmond, Virginia.
  • Dong H; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
  • Cai X; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia.
  • Mainous AG; Department of Health Services Research, Management and Policy, University of Florida, Gainesville, Florida.
  • Zgierska AE; Departments of Public Health Sciences, and Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, Pennsylvania.
  • Tuan WJ; Department of Family and Community Medicine, Penn State College of Medicine, Hershey, Pennsylvania.
  • Goyal M; Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC.
Ann Fam Med ; 20(6): 548-550, 2022.
Artículo en Inglés | MEDLINE | ID: covidwho-2140353
ABSTRACT
Our objective was to externally validate 2 simple risk scores for mortality among a mostly inpatient population with COVID-19 in Canada (588 patients for COVID-NoLab and 479 patients for COVID-SimpleLab). The mortality rates in the low-, moderate-, and high-risk groups for COVID-NoLab were 1.1%, 9.6%, and 21.2%, respectively. The mortality rates for COVID-SimpleLab were 0.0%, 9.8%, and 20.0%, respectively. These values were similar to those in the original derivation cohort. The 2 simple risk scores, now successfully externally validated, offer clinicians a reliable way to quickly identify low-risk inpatients who could potentially be managed as outpatients in the event of a bed shortage. Both are available online (https//ebell-projects.shinyapps.io/covid_nolab/ and https//ebell-projects.shinyapps.io/COVID-SimpleLab/).
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Ann Fam Med Asunto de la revista: Medicina Familiar y Comunitaria Año: 2022 Tipo del documento: Artículo País de afiliación: Afm.2872

Similares

MEDLINE
LILACS
LIS
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Ann Fam Med Asunto de la revista: Medicina Familiar y Comunitaria Año: 2022 Tipo del documento: Artículo País de afiliación: Afm.2872